Good Life Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Good Life Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,666	Closed	-$388K	–	541
2024 Q3	$388K	Buy	2,666 +993	+59%	+$144K	0.02%	400
2024 Q2	$230K	Buy	1,673 +93	+6%	+$12.4K	0.02%	402
2024 Q1	$217K	Sell	1,580 -15	-0.9%	-$2.05K	0.02%	410
2023 Q4	$217K	Buy	+1,595	New	+$195K	0.02%	398
2023 Q3	–	Sell	-1,585	Closed	-$201K	–	422
2023 Q2	$201K	Sell	1,585 -96	-6%	-$12.5K	0.02%	385
2023 Q1	$217K	Hold	1,681	–	–	0.03%	348
2022 Q4	$221K	Sell	1,681 -186	-10%	-$24K	0.03%	311
2022 Q3	$218K	Sell	1,867 -255	-12%	-$31.7K	0.03%	300
2022 Q2	$250K	Hold	2,122	–	–	0.03%	292
2022 Q1	$276K	Sell	2,122 -143	-6%	-$18.6K	0.03%	301
2021 Q4	$346K	Buy	2,265 +303	+15%	+$46.9K	0.04%	262
2021 Q3	$317K	Buy	+1,962	New	+$330K	0.04%	260

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Good Life Advisors's IBB Position: Q4 2024 in Review

Good Life Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 2,666 shares — an estimated $388K sold.

Good Life Advisors first reported a position in IBB in Q3 2021 and held it in 12 quarters. The position peaked at $388K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Good Life Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Good Life Advisors sold 2,666 iShares Biotechnology ETF shares in Q4 2024, an estimated $388K.
Good Life Advisors first reported a position in iShares Biotechnology ETF in Q3 2021 and held it in 12 quarters.
Good Life Advisors's iShares Biotechnology ETF position peaked at $388K in Q3 2024.
874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Good Life Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.